Penpulimab, identified by the unique CAS number 2350298-92-7, represents a emerging clinical antibody currently undergoing evaluation for its potential in cancer treatment. This pharmaceutical molecule is designed to https://maciewwji468484.wikiexpression.com/6595027/penpulimab_a_deep_investigation_into_the_2350298_92_7_immunoglobulin